Cancer Vaccine Week articles from February 2009

Cancer Vaccine Week archives from February 2009

Data from University of Virginia provide new insights into biopsy.
February 2, 2009... "We hypothesized that lymph nodes draining sites of cutaneous vaccination could be identified by sentinel node biopsy techniques, and that measuring T-cell response with lymphocytes obtained from these lymph nodes would provide a more sensitive...

Data on cancer vaccines published by researchers at University of North Carolina.
February 2, 2009... "Because cervical cancer mortality in the United States is twice as high among black women as white women and higher in rural areas, providing human papillomavirus (HPV) vaccine to rural black adolescents is a high priority. To identify racial...

New cancer vaccines findings from C. Harnerjay and co-authors described.
February 2, 2009... According to a study from the United States, "Health interventions developed for wealthy nations are difficult to introduce in developing countries due to a lack of sufficient technological, financial, political, or infrastructural resources."...

New cancer vaccines findings from University of Cambridge described.
February 2, 2009... "The burden of human papillomavirus (HPV)-associated ano-genital disease is significant but the ability to generate HPV virus-like particles by the synthesis and self-assembly in vitro of the major virus coat protein L1 has transformed our...

Research from University of California provides new data on cancer vaccines.
February 2, 2009... According to a study from the United States, "Testing immunotherapeutic strategies for prostate cancer has been impeded by the lack of relevant tumor models in immunocompetent animals. This opportunity is now provided by the recent development...

Research from University of South Dakota in human papillomavirus provides new insights.
February 2, 2009... In this recent report, researchers in the United States conducted a study "To test whether an immunization strategy that targets the E6 and E7 oncoproteins (E6/E7) may be an effective means to prevent the development of human papillomavirus...

Research results from A. Boudier and colleagues update understanding of life sciences.
February 2, 2009... "Double-hydrophilic block copolymer micelles were designed as vectors for ex vivo dendritic cell engineering to improve the delivery of therapeutic molecules in such immune cells. Polymethacrylic acid-b-polyethylene oxide...

Researchers from Scientific Institute of Public Health describe findings in cancer vaccines.
February 2, 2009... Current study results from the report, 'Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium,' have been published. "Before the introduction of vaccination against human...

Researchers from Department of Agriculture report on findings in immunology.
February 2, 2009... Researchers detail in 'Molecular genetics of the swine major histocompatibility complex, the SLA complex,' new data in immunology. "The swine major histocompatibility complex (MHC) or swine leukocyte antigen (SLA) complex is one of the most...

Reports from H. Navabi et al highlight recent research in cancer vaccines.
February 9, 2009... According to recent research published in the journal Vaccine, "Maturation of dendritic cells (DC) can be triggered in vitro by inflammatory cytokines or Toll-like receptor (TLR) ligands such as CpG or polyl:C. Corresponding, well-characterized...

Researchers from University of Wurzburg report details of new studies and findings in the area of cancer vaccines.
February 9, 2009... "Persistent infection with oncogenic human papillomavirus (HPV)-16 and -18 accounts for over 70% of all cases of cervical cancer. Vaccination against these HPV types has become a reality," researchers in Wurzburg, Germany report (see also...

Studies from University of Washington add new findings in the area of cancer vaccines.
February 9, 2009... "Cancer vaccines may have the most potential for clinical impact when used in the adjuvant setting when tumor burden is at its lowest. Application of cancer vaccines in the adjuvant setting, however, requires integration of immunization with...

Studies from M.A. Perales et al in the area of melanoma described.
February 9, 2009... According to recent research from the United States, "Granulocte-macrophage colony-stimulating factor (GM-CSF) enhances immune response by inducing proliferation, maturation, and migration of dentric cells (DCs) as well as expansion and...

Data on cancer gene therapy published by researchers at National Cheng-Kung University.
February 9, 2009... Data detailed in 'A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA' have been presented. According to recent research published in the journal Clinical Cancer Research, "Indoleamine 2,3-dioxygenase (IDO), an enzyme...

SAFC Pharma Augments Assay Development Capabilities.
February 9, 2009... SAFC Pharma(TM), a business segment of SAFC(R), a member of the Sigma-Aldrich(R) group (NASDAQ:SIAL), announced that it has commenced operations at its 7,000 sq. ft. state-of-the-art laboratory complex in Carlsbad, CA. Located adjacent to the...

New Cancer Tumor Vaccine Study is Seeking Volunteers: a Step in Finding a Cure.
February 9, 2009... A research team at Good Samaritan Hospital in Los Angeles is accepting new patients into a study to find a vaccine for breast cancer and other cancers. The study's aim is to develop a new, less toxic approach to treating breast cancer than...

Implants mimic infection to rally immune system against tumors.
February 9, 2009... Bioengineers at Harvard University have shown that small plastic disks impregnated with tumor-specific antigens and implanted under the skin can reprogram the mammalian immune system to attack tumors (see also Harvard University). The...

Goodwin Biotechnology, Inc. Completes GMP Manufacturing of Neogenix Oncology, Inc. Monoclonal Antibody for Upcoming Clinical Trials.
February 9, 2009... Neogenix Oncology, Inc. (Neogenix) and Goodwin Biotechnology Inc. (GBI) announced that the first phase of manufacturing of the Neogenix therapeutic monoclonal antibody, NPC-1C, had been completed, and that GMP grade product had been delivered...

FDA Provides Clear Path to NDA Submission for Pro-Pharmaceuticals' DAVANAT[R].
February 9, 2009... Pro-Pharmaceuticals, Inc. (OTCBB: PRWP) announced that the U.S. Food & Drug Administration (FDA), in a pre-New Drug Application (NDA) meeting held last December, indicated the Company will be required to conduct a Phase III trial to demonstrate...

Beshear Taps UofL to Take the Lead on Renewable Energy Research.
February 9, 2009... As President Barack Obama unveils an economic stimulus plan to invest more than $50 billion in renewable energy research, Gov. Steve Beshear is looking to the University of Louisville to take the lead in that arena. At a press conference today,...

Data on cancer vaccines discussed by researchers at University of Virginia.
February 16, 2009... "Human cancer vaccines incorporating autologous tumor cells carry a risk of implantation and subsequent metastasis of viable tumor cells into the patient who is being treated. Despite the fact that the melanoma cell preparations used in a...

Data on cancer vaccines published by researchers at Stanford University.
February 16, 2009... "Ex vivo-expanded tumor-infiltrating lymphocytes infused into lymphodepleted recipients has clear antitumor efficacy. More practical sources of such antitumor lymphocytes would broaden the application of this approach," scientists in the United...

Reports from University of Birmingham advance knowledge in cancer vaccines.
February 16, 2009... "This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular...

Research from F. Guo and co-researchers yields new findings on cancer vaccines.(Report)
February 16, 2009... According to recent research from Shanghai, People's Republic of China, "We examined the anti-tumour activity of exosomes derived from dendritic cells (DCs) in combination with cyclophosphamide (CTX) and polyinosinic-polycytidylic acid sodium...

Study data from L. Six et al provide new insights into cancer vaccines.
February 16, 2009... "EINLEITUNG: Das Zervixkarzinom ist die weltweit zweit haufigste Krebserkrankung bei Frauen. Bei gleich bleibender Tendenz der letzten Jahre und unveranderter therapeutischer Intervention ist bis 2020 eine Zunahme der Neuerkrankungen um 40%...

New findings from Florida State University, Medical Department in the area of immunization published.(Report)
February 16, 2009... According to recent research from the United States, "For human papillomavirus (HPV) vaccination to have maximum benefit to public health, both men and women should be vaccinated. Although efficacy trials in men are still ongoing, the HPV...

Scientists at National Institutes of Health report research in vaccines.
February 16, 2009... According to a study from the United States, "Nucleic acid-based vaccines are effective in infectious disease models but have yielded disappointing results in tumor models when tumor-associated self-antigens are used. Incorporation of helper...

Research on cancer vaccines immunology reported by F. Meklat et al.(Report)
February 16, 2009... A new study, 'Identification of protamine 1 as a novel cancer-testis antigen in early chronic lymphocytic leukaemia,' is now available. According to a study from the United States, "Early chronic lymphocytic leukaemia (CLL) is an ideal disease...

African-Americans aware and accepting, but often do not receive, the HPV vaccine.
February 16, 2009... Although only 25 percent of eligible African-American adolescents have received the HPV vaccine, a new survey presented at the American Association for Cancer Research conference on the Science of Cancer Health Disparities, suggests they have a...

GenVec to Present at the 11th Annual BIO CEO & Investor Conference.(Conference news)
February 16, 2009... GenVec, Inc. (Nasdaq:GNVC) announced that Paul H. Fischer, Ph.D., GenVecEs President and CEO, will present a company overview highlighting recent developments at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009 at...

Measles virus may be effective prostate cancer treatment.
February 16, 2009... A new study appearing in The Prostate has found that certain measles virus vaccine strain derivatives, including a strain known as MV-CEA, may prove to be an effective treatment for patients with advanced prostate cancer. The findings show that...

Reports from University of Pennsylvania add new data to research in cancer vaccines.
February 23, 2009... "Human papillomavirus infection, the most common sexually transmitted infection in the United States, is associated with the development of cervical cancer," scientists in the United States report (see also Cancer Vaccines). "The new human...

Researchers from University of Pennsylvania, Medical Department provide details of new studies and findings in the area of cancer vaccines.
February 23, 2009... According to recent research from the United States, "Our laboratory is interested in how immunogenicity may be modulated in vivo in order to better design more effective immunotherapeutics against cancer. Our main approach is to use a...

Studies from L.G. Almeida and co-researchers update current data on cancer vaccines.
February 23, 2009... "The potency of the immune response has still to be harnessed effectively to combat human cancers. However, the discovery of T-cell targets in melanomas and other tumors has raised the possibility that cancer vaccines can be used to induce a...

Study findings on cancer vaccines are outlined in reports from Stanford University.
February 23, 2009... According to a study from the United States, "3 Tor Life aims to increase hepatitis B virus (HBV) awareness and reduce the high prevalence of undiagnosed, chronic HBV infection and susceptibility among Asian/Pacific Islander (API) adults. This...

Wayne State University reports research in cancer vaccines.
February 23, 2009... According to recent research published in the journal Cancer Research, "Genetic regulation of immune reactivity to Her-2 vaccination and the consequent antitumor effect was tested in human Her-2 transgertic (Tg) mice of C57BL/6 (B6), BALB/c...

Findings from New York University, University Cancer Institute provide new insights into malaria vaccines.
February 23, 2009... New investigation results, 'Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimod,' are detailed in a study published in Infection and...

New Intellectual Property Patent for Advaxis Issued.
February 23, 2009... The U.S. Patent and Trademark Office (USPTO) issued today patent 7,488,487 oMethods of Inducing Immune Response Through the Administration of Auxotrophic Attenuated DAL/DAT Double Mutant Listeria Strains,o by Dr. Fred Frankel, et al, which is...

Geron Appoints Audit Committee Members.
February 23, 2009... Geron Corporation (Nasdaq:GERN) announced the appointment of Patrick J. Zenner, a current member of the Board of Directors, to the Audit Committee. Also, the Board of Directors appointed Mr. Edward V. Fritzky, currently a member of the Audit...